Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy
View Patent ↗The invention provides a method for determining the activation status of receptor tyrosine kinase (RTK) pathways in either cell samples or patient samples by measuring receptor dimerization and relative amounts of protein-protein complexes or activated effector proteins that are characteristic of an RTK pathway. The invention also provides a method of using such status information to select patients responsive to pathway-specific drugs, and more particularly, to methods for measuring ErbB receptors and receptor complexes and using such information to select patients responsive to ErbB pathway-specific drugs. Preferably, methods of the invention are implemented by using sets of binding compounds having releasable molecular tags that are specific for multiple components of one or more complexes formed in RTK activation. After binding, molecular tags are released and separated from the assay mixture for analysis.
1. A method of profiling one or more components of a signaling pathway comprising one or more cell surface receptors, cell surface receptor complexes, signaling complexes, or effector proteins, the method comprising the steps of:
providing for each of the one or more components at least one cleaving probe specific for a first antigenic determinant on said one or more components and having a cleavage-inducing moiety with an effective proximity;
providing one or more binding compounds specific for a second antigenic determinant of each of the one or more components, wherein each cleaving probe and binding component comprises an antibody or antigen binding fragment of an antibody, such that each binding compound has one or more molecular tags each attached thereto by a cleavable linkage, and such that the one or more molecular tags attached to different binding compounds have different separation characteristics so that upon separation molecular tags from different binding compounds form distinct peaks in a separation profile;
mixing the cleaving probes, the binding compounds, and the one or more components such that cleaving probes specifically bind to the first antigenic determinants and binding compounds specifically bind to the second antigenic determinants and such that cleavable linkages of the binding compounds are within the effective proximity of cleavage-inducing moieties of the cleaving probes so that molecular tags are released; and
separating and identifying the released molecular tags to determine the presence or absence or the amount of the one or more components of the signaling pathway.
2. The method of claim 1 wherein said step of mixing includes generating an active species by said cleavage-inducing moiety, the active species cleaving said cleavable linkages within said effective proximity.
3. The method of claim 2 wherein whenever said one or more components includes a cell surface receptor complex or a signaling complex, said steps of providing include providing a cleaving probe specific for a first protein of the cell surface receptor complex or the signaling complex and providing one or more binding compounds specific for a second protein of the cell surface receptor complex or signaling complex.
4. The method of claim 3 wherein whenever said one or more components includes an effector protein that has a post-translational modification site, said steps of providing include providing a second binding compound specific for the post-translational modification site, wherein the post-translational modification site is different from said second antigenic determinant.
5. The method according to claims 1 , 2 , 3 , or 4 wherein said signaling pathway is an mTOR pathway, a Ras-MAPK pathway, or a PI3K-Akt pathway.
6. The method of claim 2 wherein said cleavage-inducing moiety is a photosensitizer and said active species is singlet oxygen.
7. The method of claim 2 wherein said separation characteristic is electrophoretic mobility and wherein said separation profile is an electropherogram.